Navigation Links
Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
Date:1/4/2008

- VELCADE(R) (bortezomib) for Injection sales grew 20% to $265 million in

2007- - sNDA submitted for VELCADE expansion into front-line multiple myeloma - - MLN0002 core bridging studies fully enrolled, showing favorable results -

- New proteasome inhibitor, MLN2238, enters development pipeline -

- On track to exceed 2007 net income financial guidance -

CAMBRIDGE, Mass., Jan. 4 /PRNewswire-FirstCall/ -- Building on a record year in 2007, Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced 2008 corporate goals and financial guidance. These goals, along with selected financial and operational results from 2007, will be presented at the 26th Annual JPMorgan Healthcare Conference on January 9, 2008, in San Francisco, Calif.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"The past year was the most successful in the Company's 15-year history with outstanding accomplishments across commercial, R&D and operations. Millennium is well positioned for strong growth in 2008 and beyond," said Deborah Dunsire, M.D., President and Chief Executive Officer, Millennium. "The expected launch in front-line multiple myeloma is the next catalyst for VELCADE. Our late-stage product candidate, MLN0002, is approaching pivotal trials in inflammatory bowel diseases, representing the next revenue growth driver, and our innovative R&D organization continues to fuel the pipeline. We begin 2008 in the strongest financial position in the Company's history and remain firmly committed to continued top- and bottom-line growth."

In 2008, the Company's goals will focus on three strategic
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
2. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
3. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
4. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
5. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
6. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results
7. Life Sciences Leader Joins Millennium Board of Directors
8. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
11. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... particles are intensively investigated for application as ... agents and components in photonics and molecular ... fundamental for understanding physical and chemical properties, ... University, USA, have demonstrated that high-resolution electron ... three-dimensional structure in which all gold atoms ...
(Date:8/22/2014)... -- Research and Markets has announced the ... & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market ... The global molecular biology enzymes market ... expected to grow at a CAGR of 13.74% to ... & reagents find applications in a large number of ...
(Date:8/22/2014)... 22, 2014 “Our nation's healthcare ... a national disgrace. Furthermore, every governmental and professional ... current, deplorable state of unorganized dysfunction shares in ... to merely serve as a device to use ... colossal failure(s) that have accumulated through the years ...
(Date:8/21/2014)... international research team including DESY scientists has observed tiny ... team reports in the journal Science that ... inside the nanodroplets. It is the first time that ... larger samples of what is known as superfluid helium, ... our best expectations," says Andrey Vilesov of the University ...
Breaking Biology Technology:A breakthrough in imaging gold nanoparticles to atomic resolution by electron microscopy 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 35 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2Scientists observe quantum vortices in cold helium droplets 2
... , SOUTH SAN FRANCISCO, Calif., July 23 Anesiva, ... its Current Report on Form 8-K filed with the Securities and ... on April 1, 2009, a letter from the NASDAQ Stock Market ... not in compliance with Marketplace Rule 4450(a)(3) (which has since been ...
... , , ANAHEIM, Calif., ... will showcase a wide spectrum of new and updated products that ... the products on display will be a new version of the ... the product,s speed, precision, and clinical flexibility. The new software ...
... , , SUNNYVALE, ... development of endovascular devices for the treatment of chronic total occlusions ... of Chief Operating Officer. Chris previously held the position of Executive ... of experience in Medical Devices including the last 2 years at ...
Cached Biology Technology:Anesiva Receives NASDAQ Delisting Staff Determination Letter 2Anesiva Receives NASDAQ Delisting Staff Determination Letter 3Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting 2Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting 3Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting 4FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer 2
(Date:8/21/2014)... Algae might seem easy to ignore, but they are ... animals depend upon. Humans are increasingly dependent on algae, ... atmosphere and sink it to the bottom of the ... and laboratory experiments, researchers have evidence showing that viruses ... the algae,s blooms, even when all else stays essentially ...
(Date:8/21/2014)... researchers from Beth Israel Deaconess Medical Center (BIDMC ) ... Most Influential Scientific Minds 2014," a comprehensive list ... web resource for science metrics and research performance analysis. ... most influential "are performing and publishing work that their ... science," according to a Thomson Reuters statement. Researchers were ...
(Date:8/21/2014)... 2014 , WHERE: , San Diego Convention ... 92101 , WHAT: , Invited and platform ... research in human genetics. Examples of sessions include: ... rare genetic variants in health and disease, the ... sensitivity (Saturday, Oct. 18, 5:30-7:30 pm) , Crowdsourced ...
Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3American Society of Human Genetics 2014 Annual Meeting 2
... A new report launched today by the International Osteoporosis ... Pharmaceutical Industry Associations (EFPIA) reveals that the burden of ... concludes that in Europe,s five largest countries and Sweden ... occurred in 2010 the equivalent of 280 fractures ...
... better ways of encapsulating medicine so that it can reach ... for the first time living human cells to ... agents. The report appears in ACS, journal Nano Letters ... that the human body is very efficient at getting rid ...
... CHICAGO (June 15, 2011) A study of Canadian home-care ... ongoing medical care at home. The study, published in the ... the journal of the Society for Healthcare Epidemiology of America, ... in home-care patients to avoid misuse that could decrease the ...
Cached Biology News:Landmark report reveals immense burden of osteoporotic fractures in Europe 2Study hints at antibiotic overuse in home-care patients 2
... Immunogen: Synthetic peptide derived from the C-terminal ... growth factor D iris-expressed growth factor spinal ... mouse and rat by one amino acid ... kDa human mouse and rat PDGF-D proteins. ...
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support....
...
... Fd. ELISA Specificity: (4) ,human IgG subclass 1 ... subclass 3 100% ,human IgG subclass 4 ... 100% ... 0.04% ,human IgG Fab ...
Biology Products: